NCT03053128View on ClinicalTrials.gov

Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 20, 2017

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2019

Conditions
Cardiac Ischemia
Interventions
DEVICE

Cardiac shock wave therapy

Patients in CSWT group will receive CSWT for a 3-month therapy, located in their ischemia area with a energy of 0.09mJ/mm2. Patients will get therapy on every first week of the month and rest for following three weeks.

OTHER

Sham cardiac shock wave (Control group)

Patients in sham CSWT group will receive sham cardiac shock wave, which is segregated by an air cushion.

Trial Locations (1)

100730

Beijing Hospital, Beijing

All Listed Sponsors
lead

Beijing Hospital

OTHER_GOV

NCT03053128 - Implication of Cardiac Shock Wave Therapy on Coronary Artery Disease | Biotech Hunter | Biotech Hunter